Bromo-PEG2-CH2-Boc
CAS No. 1807518-63-3
Bromo-PEG2-CH2-Boc ( —— )
Catalog No. M23819 CAS No. 1807518-63-3
Bromo-PEG2-CH2-Boc is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
10MG | 30 | In Stock |
|
25MG | 45 | In Stock |
|
50MG | 64 | In Stock |
|
100MG | 92 | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameBromo-PEG2-CH2-Boc
-
NoteResearch use only, not for human use.
-
Brief DescriptionBromo-PEG2-CH2-Boc is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.
-
DescriptionBromo-PEG2-CH2-Boc is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs[1].
-
Synonyms——
-
PathwayPROTACs
-
TargetPROTAC
-
RecptorPEGs;Alkyl/ether
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1807518-63-3
-
Formula Weight283.2
-
Molecular FormulaC10H19BrO4
-
Purity>98% (HPLC)
-
SolubilityDMSO:10 mM
-
SMILESCC(C)(C)OC(=O)COCCOCCBr
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562
molnova catalog
related products
-
PAC1
PAC1 (Compound PAC1) is a novel PROTAC antibody conjugate, more potent estrogen receptor-alpha (ERα) degrader compared to PROTAC without antibody conjugation.
-
MZ1
MZ1 is aPROTAC that tethers JQ1 to a ligand for the E3 ubiquitin ligase VHL, triggers, induces degradation of the BET bromodomain BRD4.
-
Bromo-PEG2-CH2-Boc
Bromo-PEG2-CH2-Boc is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.